Metrics to compare | JULPHAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJULPHARPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.3x | 6.3x | −0.5x | |
PEG Ratio | 0.10 | 0.14 | 0.00 | |
Price/Book | 1.3x | 4.4x | 2.6x | |
Price / LTM Sales | 1.1x | 2.3x | 3.2x | |
Upside (Analyst Target) | 2.9% | 37.6% | 50.8% | |
Fair Value Upside | Unlock | 13.5% | 7.7% | Unlock |
Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wound care management, dermatology, endocrine, gynecology and women care, anemia, antibiotics, decongestants and other nasal preparations, hyperkalemia and hyperphosphatemia, urinary antispasmodics, erectile dysfunction, benign prostatic hyperplasia, and gastrointestinal tract. The company is also involved in transportation activities; general trading; distribution, wholesale, and retail trading of medicines and cosmetic products; facilities management services, health treatment undertaking services, and hospitals management; investment in commercial, industrial, and healthcare enterprises; agent; sale of cosmetics; export and import activities; and trading in medical equipment. Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is headquartered in Ras al-Khaimah, the United Arab Emirates.